AstraZeneca Pharma grants authority to Pfizer for injectable antibiotic products

20 Jan 2017 Evaluate

AstraZeneca Pharma India has granted certain authority (through a Delegation of Authority (DOA)) to Pfizer, which shall include, authority to carry out the activities of pricing and reimbursement negotiations, promotional, marketing, tendering, bidding, and distribution in relation to the identified injectable antibiotic products. Pursuant to this, Meronem IV injection which is currently marketed in India by AstraZeneca Pharma India is expected to be transitioned to Pfizer.

AstraZeneca Pharma India is a global biopharmaceutical company. The company is engaged in the discovery, development and commercialization of medicines for core areas of healthcare, including cardiovascular/metabolic disease, cancer and respiratory, inflammatory and autoimmune disease. The company operates through two segments Healthcare and Clinical Trial.


Astrazeneca Pharma I Share Price

5271.00 -48.75 (-0.92%)
28-Mar-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1620.50
Dr. Reddys Lab 6171.85
Cipla 1494.65
Zydus Lifesciences 1013.75
Lupin 1617.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.